Are we in another unavoidable 'diagnose and adios' era?

Tsong-Hai Lee,Ku-Chou Chang

DOI: https://doi.org/10.1161/STR.36.9.1852

IF: 10.17

2005-09-01

Stroke

Abstract:None of us in stroke management regret the passage of the “diagnose and adios” era, humorously criticized earlier. We know well that opportunities for stroke management are arising for more definitive studies. A revolution in imaging, the rush to apply results from clinical trials, and attempts to shorten the time frame for action are daily practice because neurologists are interventionists similar to their colleagues in cardiology and emergency medicine.1 However, with the pace of accumulated data from leisurely approached genetic association studies, we confront the issue of hereditary risk factors. In this issue of Stroke , Howard et al2 report on a well-organized, population-based study in 15- to 44-year-old women. Among the 5 nitric oxide synthase ( NOS)3 polymorphisms in 110 cases (46% black) with ischemic stroke and 206 controls (38% black) who were recruited over 4 years, these investigators found that the −922 G/A and −786 T/C polymorphisms may be associated with ischemic stroke susceptibility among young black women. Although the small sample size …